Bicara Therapeutics Inc. · NASDAQ:BCAX
Vestal Point Capital, LP reported a 6.50% stake in Bicara Therapeutics Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Vestal Point Capital, LP reported a 6.50% stake in Bicara Therapeutics Inc., 3,575,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 6.50%
- Shares
- 3,575,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vestal Point Capital, LP | 6.50% | 3,575,000 |
| Ryan Wilder | 6.50% | 3,575,000 |
Source
Related
- Bicara Therapeutics Inc.
- Vestal Point Capital, LP
- Bicara Therapeutics Inc. shareholders
- Schedule 13G/A · Vestal Point Capital, LP · May 15, 2026
- Schedule 13G/A · Vestal Point Capital, LP · Aug 14, 2025
- Schedule 13G · Vestal Point Capital, LP · May 15, 2025
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Oct 7, 2026
- Form 4 · Cohlhepp Ryan · Sep 10, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Hyep Ivan · Aug 12, 2026
- Form 4 · Mazumdar Claire · Aug 12, 2026